NuCana Plc (NCNA)
0.8899
0.00 (0.00%)
USD |
NASDAQ |
Nov 18, 10:54
NuCana EPS Diluted (Quarterly) : -0.4704 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4704 |
| June 30, 2026 | -1.007 |
| March 31, 2026 | -1.28 |
| December 31, 2025 | -0.7979 |
| September 30, 2025 | -0.1349 |
| June 30, 2025 | -31.11 |
| March 31, 2025 | -102.57 |
| December 31, 2024 | -29.54 |
| September 30, 2024 | -2.427 |
| June 30, 2024 | -3.894 |
| March 31, 2024 | -4.046 |
| December 31, 2023 | -4.534 |
| September 30, 2023 | -4.022 |
| June 30, 2023 | -3.234 |
| March 31, 2023 | -4.562 |
| December 31, 2022 | -8.607 |
| September 30, 2022 | -2.574 |
| June 30, 2022 | -2.361 |
| Date | Value |
|---|---|
| March 31, 2022 | -5.451 |
| December 31, 2021 | -8.896 |
| September 30, 2021 | -5.361 |
| June 30, 2021 | -6.150 |
| March 31, 2021 | -6.578 |
| December 31, 2020 | -7.992 |
| September 30, 2020 | -7.723 |
| June 30, 2020 | -5.758 |
| March 31, 2020 | -3.961 |
| December 31, 2019 | -7.753 |
| September 30, 2019 | -3.748 |
| June 30, 2019 | -4.525 |
| March 31, 2019 | -5.498 |
| December 31, 2018 | -3.662 |
| September 30, 2018 | -2.606 |
| June 30, 2018 | -1.360 |
| March 31, 2018 | -6.958 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0364 |
| BioNTech SE | 0.8399 |
| Silence Therapeutics Plc | -0.075 |
| Autolus Therapeutics Plc | -0.2068 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.160M |
| Total Expenses (Quarterly) | 2.160M |
| Enterprise Value | -19.21M |
| Earnings Yield | -399.5% |
| Normalized Earnings Yield | -393.50 |